Why is "Simeprevir" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-07-09 08:07:53
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Simeprevir entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-07-09 and was most recently seen on 2026-07-09.
Wikipedia Overview
Simeprevir, sold under the brand name Olysio among others, is a medication used in combination with other medications for the treatment of hepatitis C. It is specifically used for hepatitis C genotype 1 and 4. Medications it is used with include sofosbuvir or ribavirin and peginterferon-alfa. Cure rates are in 80s to 90s percent. It may be used in those who also have HIV/AIDS. It is taken by mouth once daily for typically 12 weeks.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
A simeprevir-inducible molecular switch for the control of cell and gene therapies - Nature
-
Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study - The Lancet
-
Olysio (simeprevir) for the Treatment of Chronic Hepatitis C (CHC) - Clinical Trials Arena
-
OLYSIO® (simeprevir) Gains Additional FDA Approval as Once-Daily, All-Oral Interferon- and Ribavirin-Free Treatment Option in Combination with Sofosbuvir for Adults with Genotype 1 Chronic Hepatitis C Infection - PR Newswire
-
Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment - www.elsevier.com
-
Daclatasvir plus simeprevir are effective against hepatitis C genotype 1b - Aidsmap
-
Recent advances and future directions in the management of hepatitis C infections - National Institutes of Health (NIH) | (.gov)
-
Simultaneous spectrofluorimetic determination of remdesivir and simeprevir in human plasma | Scientific Reports - Nature
-
Janssen to Discontinue Hepatitis C Development Program - drugdiscoverytrends.com
-
Combination Therapy Offers Quicker, Less Toxic Eradication of Hepatitis C in Patients with Transplanted Livers - Mayo Clinic News Network
-
Olefin metathesis catalysts | EUMET Project | Results in Brief | FP7 - CORDIS | European Commission
-
Renowned Liver Disease Specialist Named Director of Hepatology at NYU Langone Health - NYU Langone Health
-
FDA Approves Olysio-Sovaldi Hep C Combo - hepmag.com
-
FDA approves Olysio/Sovaldi combination in hep C - PMLiVE
-
Johnson & Johnson pulls plug on Medivir-Achillion hep C cocktail to focus on hep B - Fierce Biotech
-
Sofosbuvir-based therapy effective for hepatitis C patients with decompensated cirrhosis - Aidsmap
-
Efficient Suppression of Hepatitis C Virus Replication by Combination Treatment with miR-122 Antagonism and Direct-acting Antivirals in Cell Culture Systems - Nature
-
European liver specialists recommend 'mix-and-match' approach to new hepatitis C drugs - Aidsmap
-
An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors - Nature
-
More UK patients will now be eligible for two costly hepatitis C treatments - The Pharmaceutical Journal
-
Cryo-EM structures of human organic anion transporting polypeptide OATP1B1 - Nature
-
People infected by hepatitis C in Canada have limited access to direct-acting antivirals - EurekAlert!
-
NICE backs new hepatitis C treatments - PMLiVE
-
Spanish hepatitis C patients to march for access to expensive new drugs - EL PAÍS English
-
New Drug Product: OLYSIO - Medical Professionals Reference
-
Janssen takes on GSK hep C drug - Pharmafile
-
Six-week antibiotic tx effective for diabetic foot osteomyelitis - Medical Xpress
-
FDA approves breakthrough drug for treatment of hepatitis C - WQAD
-
Could new hepatitis C drugs bust state budgets? - USA Today
-
Treatments for hepatitis C get provisional backing for NHS use - Nursing Times
-
A Global Study Led by CU Medicine and HKUMed Discovers a Hepatitis C Virus Drug as Potent Treatment for COVID-19 - All News - Media - The University of Hong Kong (HKU)
-
Meniran Herbs to Fight Against Hepatitis C Virus - Universitas Airlangga Official Website
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.